Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylprednisolone as Adjunct to Endovascular Thrombectomy for Patients With Acute Ischemic Strokes With Large Infarct: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial (MIRACLE)

NCT06360458 is registered in ClinicalTrials.gov with Wan-Jin Chen as lead sponsor.

NCT NCT06360458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06360458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylprednisolone as Adjunct to Endovascular Thrombectomy for Patients With Acute Ischemic Strokes With Large Infarct: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial (MIRACLE)
Lead sponsor
Wan-Jin Chen
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 1, 2024
Completion date
June 30, 2030
Enrollment
928 (actual)
Sites
99

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, large infarct core